Related references
Note: Only part of the references are listed.Differential Effects of Targeting Notch Receptors in a Mouse Model of Liver Cancer
Erik G. Huntzicker et al.
HEPATOLOGY (2015)
Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine
Marin E. Healy et al.
JOURNAL OF HEPATOLOGY (2015)
4EBP1/eIF4E and p70S6K/RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-oncogenes in Mice
Chunmei Wang et al.
HEPATOLOGY (2015)
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Xin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Liver-Specific Knockout of GRP94 in Mice Disrupts Cell Adhesion, Activates Liver Progenitor Cells, and Accelerates Liver Tumorigenesis
Wan-Ting Chen et al.
HEPATOLOGY (2014)
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska et al.
NATURE MEDICINE (2014)
Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice
H. Ye et al.
ONCOGENE (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis Implications for the treatment of human liver cancer
Chunmei Wang et al.
CELL CYCLE (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Augusto Villanueva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
Hye-Lim Ju et al.
PLOS ONE (2013)
Role of the microenvironment in hepatocellular carcinoma development and progression
Sheng-Di Wu et al.
CANCER TREATMENT REVIEWS (2012)
Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
Sarah-Fee Katz et al.
GASTROENTEROLOGY (2012)
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways
Coral Ho et al.
HEPATOLOGY (2012)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
Jimmy K. Stauffer et al.
CANCER RESEARCH (2011)
A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation
Victor W. Ho et al.
CANCER RESEARCH (2011)
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
Diego F. Calvisi et al.
GASTROENTEROLOGY (2011)
Modeling Hepatitis B Virus X-Induced Hepatocellular Carcinoma in Mice With the Sleeping Beauty Transposon System
Vincent W. Keng et al.
HEPATOLOGY (2011)
Sorafenib Suppresses Postsurgical Recurrence and Metastasis of Hepatocellular Carcinoma in an Orthotopic Mouse Model
Yu-Xiong Feng et al.
HEPATOLOGY (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
Mia Kumar et al.
CELL AND BIOSCIENCE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
Mustafa S. Ascha et al.
HEPATOLOGY (2010)
Cancer gene discovery in hepatocellular carcinoma
Lars Zender et al.
JOURNAL OF HEPATOLOGY (2010)
Duration of Expression and Activity of Sleeping Beauty Transposase in mouse liver following hydrodynamic DNA delivery
Jason B. Bell et al.
MOLECULAR THERAPY (2010)
A Transposon and Transposase System for Human Application
Perry B. Hackett et al.
MOLECULAR THERAPY (2010)
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
Sayaka Inokuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of Novel Oncogenes and Tumor Suppressors in Hepatocellular Carcinoma
Sandrine Imbeaud et al.
SEMINARS IN LIVER DISEASE (2010)
Beta-Catenin Activation Promotes Liver Regeneration after Acetaminophen-Induced Injury
Udayan Apte et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Robe of Cyclin D1 as a Mediator of c-Met- and beta-Catenin-Induced Hepatocarcinogenesis
Mohini A. Patil et al.
CANCER RESEARCH (2009)
Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis
Aranzazu Sanchez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Experimental mouse models for hepatocellular carcinoma research
Femke Heindryckx et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
Naiara Beraza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis
Chuan-Rui Xu et al.
MOLECULAR CANCER RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The use of GEM models for experimental cancer therapeutics
Aarthi Gopinathan et al.
DISEASE MODELS & MECHANISMS (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Experimental models of hepatocellular carcinoma
Philippa Newell et al.
JOURNAL OF HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer
Susie A. Lee et al.
HEPATOLOGY (2008)
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis
Christof Schlaeger et al.
HEPATOLOGY (2008)
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: Implications for HCV-associated hepatocarcinogenesis
Naoki Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Hydrodynamic gene delivery: Its principles and applications
Takeshi Suda et al.
MOLECULAR THERAPY (2007)
Distinct pathways of genomic progression to benign and malignant tumors of the liver
Aaron D. Tward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Protonged expression of a tysosomat enzyme in mouse tiver after Sleeping Beauty transposon-mediated gene detivery:: imptications for non-virat gene therapy of mucopotysaccharidoses
Elena L. Aronovich et al.
JOURNAL OF GENE MEDICINE (2007)
Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma
Tom Luedde et al.
CANCER CELL (2007)
Non-alcoholic steatohepatitis and hepatocellular carcinoma: Lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice
Sumio Watanabe et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Contributions of human tumor xenografts to anticancer drug development
EA Sausville et al.
CANCER RESEARCH (2006)
Genetics of hepatocellular tumors
P. Laurent-Puig et al.
ONCOGENE (2006)
Comparative and integrative functional genomics of HCC
J-S Lee et al.
ONCOGENE (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse
CM Carlson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences
DQ Lou et al.
CANCER LETTERS (2005)
Activation of the canonical Wnt/β-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer
DF Calvisi et al.
JOURNAL OF HEPATOLOGY (2005)
Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours
J Borlak et al.
ONCOGENE (2005)
β-catenin is temporally regulated during normal liver development
A Micsenyi et al.
GASTROENTEROLOGY (2004)
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine
G Bocci et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas
S Colnot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
JS Lee et al.
NATURE GENETICS (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Hepatocarcinogenesis in mice with beta-catenin and Ha-Ras gene mutations
N Harada et al.
CANCER RESEARCH (2004)
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
TH Hu et al.
CANCER (2003)
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye et al.
NATURE MEDICINE (2003)
E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models
EA Conner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
MM Hassan et al.
HEPATOLOGY (2002)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
Molecular pathogenesis of human hepatocellular carcinoma
SS Thorgeirsson et al.
NATURE GENETICS (2002)
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
A Tannapfel et al.
ONCOGENE (2001)
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
EA Conner et al.
ONCOGENE (2000)
Share Paper
